After a Pandemic Growth Spurt, COVID-19 Test Maker Biomeme is Moving its HQ to North Broad and Looking to the Future
About this time last year, Biomeme — makers of a rapid COVID-19 test and other diagnostic hardware — had about 35 people in its 10th and Chestnut streets HQ.
Enter a global pandemic. The company, now about 280 employees across the U.S. and about 120 in the Philadelphia region, has outgrown its office. It will join esports company Nerd Street Gamers at a 44,000-square-foot office, lab, testing and manufacturing in a new corporate headquarters at 401 N. Broad St., owned by Netrality, operator of fiber-dense data centers that allow for super-fast internet.
Biomeme currently produces mobile, real time-PCR devices and other testing hardware. It’s currently manufacturing products including a FDA emergency use authorized COVID-19 test.
The move will help the expansion of the company’s manufacturing capacity, and is supported by a $3 million grant from Pennsylvania’s Redevelopment Assistance Capital Program. It will allow Biomeme to produce more than 10 million tests annually, the company said. Biomeme has been working with Strada Architecture LLC to build out the space to meet all of its office, manufacturing and lab needs.
Read the full article here.